基于政策一致性指数模型的医学领域科研诚信政策量化评价OA
Quantitative Evaluation of Research Integrity Policies in Medical Field Based on Policy Modeling Consistency Index Model
目的 通过构建医学领域科研诚信政策评价指标体系,对我国主要科研诚信政策进行量化评估,旨在揭示科研诚信政策在医学领域的适用性水平与结构性短板,从而为提升我国医学领域科研诚信治理的科学性与实践效能提供实证依据与优化路径.方法 收集2010 年1 月至2025 年1 月国家及部委层面发布的18 项科研诚信政策文件,通过文本挖掘和关键词分析构建基于政策一致性指数模型的评价指标体系,量化评估政策的一致性与有效性,并依据得分范围将政策分为优秀、良好、中等、不良4 个等级.结果 18 项政策一致性指数均值为6.27,整体呈现良好水平,凹陷指数均值为2.73,但存在明显参差,其中优秀级3 项、良好级6 项、中等级9 项.从各维度均值看,政策功能与政策时效维度表现稳固,但在政策客体与政策作用范围维度上存在显著不足,其均值分别为0.59 和0.44.结论 我国医学领域科研诚信政策整体表现良好,但存在缺乏国际化视野、政策客体单一、政策执行刚性和实操性不足等短板,建议采取与全球标准对接、构建多元主体协同治理网络、增强政策执行刚性、提升内容可操作性等措施,系统性地优化我国医学领域科研诚信政策体系,以整体提升我国医学领域科研诚信治理水平.
Objective To quantitatively evaluate China's core research integrity policies by construc-ting an evaluation index system specific to the medical field and reveal the applicability and structural shortcom-ings of these policies,thereby providing empirical evidence and optimization pathways for enhancing the scientific rigor and practical effectiveness of research integrity governance in China.Methods Eighteen research integrity policy documents issued at the national level by the central government and ministries from January 2010 to Janu-ary 2025 were collected.An evaluation framework based on the policy modeling consistency index model was con-structed via text mining and keyword analysis to quantitatively assess the consistency and effectiveness of these poli-cies.According to their scores,the policies were rated as excellent,good,medium,or bad grade.Results The 18 policies showed the average policy modeling consistency index of 6.27 and the sag index of 2.73,which indi-cated good overall performance but with clear disparities.Among them,3 policies were rated as excellent,6 as good,and 9 as medium.Analysis of the dimensional averages revealed that while the policies performed robustly in terms of policy function and policy timeliness,they exhibited significant shortcomings in the dimensions of pol-icy target and policy scope,with average scores of 0.59 and 0.44,respectively.Conclusions While China's medical research integrity policy framework is generally effective,it exhibits clear structural shortcomings,inclu-ding a lack of international perspective,monolithic policy targets,insufficient enforcement rigidity,and low op-erability.Accordingly,it is recommended that measures such as aligning with global standards,establishing a multi-stakeholder collaborative governance network,strengthening policy enforcement,and improving policy op-erability should be adopted.These measures will help to systematically optimize China's medical research integri-ty policy system,thereby enhancing the overall governance level in this domain.
程俞小倩;闵开元;刘泽坤;杨珑平;李青
中国医学科学院北京协和医学院 卫生健康管理政策学院,北京 100730中国医学科学院北京协和医学院 基础医学研究所重大疾病共性机制研究全国重点实验室,北京 100005中国医学科学院北京协和医学院 卫生健康管理政策学院,北京 100730中国医学科学院北京协和医学院 卫生健康管理政策学院,北京 100730中国医学科学院北京协和医学院 卫生健康管理政策学院,北京 100730
医药卫生
医学领域科研诚信政策一致性指数政策量化评估
medical fieldresearch integritypolicy modeling consistency indexquantitative evaluation of policies
《中国医学科学院学报》 2026 (2)
258-265,8
中国医学科学院医学与健康科技创新工程(2021-12M-1-046)
评论